AcouSort AB

ACOU · Nasdaq Stockholm · Healthcare

3.58SEK +46.1%last day

Price as of 2 October 2026

The price over the past year, with dividends: +14.0%

Performance

1 month

+11.9%

1 year

+14.0%

3 years, per year

−48.2%

5 years, per year

−31.7%

Largest fall, 3 years

−92.3%

Below the peak now

−88.7%

Volatility, 1 year

94.3%

Return with dividends reinvested.

Key figures

P/E

negative earnings

P/B

7.5

Dividend yield

0.0%

Return on equity

−114.5%

Net margin

−140.8%

Market value

8 m USD

Quality, value and trend

Where AcouSort stands against every Nordic stock today. 100 is best.

Quality46

Profitability and a sound balance sheet over time. Better than 46% of Nordic stocks.

Value4

The price measured against earnings, assets and cash flow. Better than 4% of Nordic stocks.

Trend55

The price development over the past year. Better than 55% of Nordic stocks.

Combined20

Quality, value and trend together. Better than 20% of Nordic stocks.

About AcouSort

AcouSort AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 11 employees.

AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, a module that enables in-line analysis of blood plasma from whole blood samples; Acoustic Separation Module, a microfluidic solution that provides continuous separation, washing or up-concentration of cells; Acoustic Trapping Module, a microfluidic cell sorters or quality control systems for bioreactors and cell therapy production; AQC Module, an in-line optical analysis of particle s…

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis